As of April 29, 2025, X4 Pharmaceuticals (XFOR) has a market cap of $25.181 million USD. According to our data, X4 Pharmaceuticals is ranked No.8466 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $25.18 M |
-79.88%
|
Dec 31, 2024 | $0.13 B |
-12.51%
|
Dec 29, 2023 | $0.14 B |
-15.51%
|
Dec 30, 2022 | $0.17 B |
-56.64%
|
Dec 31, 2021 | $0.39 B |
-64.39%
|
Dec 31, 2020 | $1.10 B |
-39.91%
|
Dec 31, 2019 | $1.82 B |
-23.13%
|
Dec 31, 2018 | $2.37 B |
-81.82%
|
Dec 29, 2017 | $13.06 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Vir Biotechnology
VIR
|
$0.83 B |
-0.000 M
|
![]() USA
|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.77 B |
0.000 M
|
![]() USA
|
![]() Kiniksa Pharmaceuticals
KNSA
|
$1.89 B |
0.801 B
|
|
![]() Apellis Pharmaceuticals
APLS
|
$2.29 B |
0.000 M
|
![]() USA
|
![]() Allakos
ALLK
|
$29.46 M |
0.000 M
|
![]() USA
|
![]() Immunovant
IMVT
|
$2.59 B |
0.000 M
|
![]() USA
|
![]() Alector
ALEC
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Atara Biotherapeutics
ATRA
|
$44.00 M |
0.000 M
|
![]() USA
|
![]() Kura Oncology
KURA
|
$0.53 B |
0.000 M
|
![]() USA
|
Market Cap | = | XFOR Stock Price | * | XFOR Shares Outstanding |
= | $4.35 | * | 5.79 M | |
= | $25.18 M |